| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 616,107 | | Cost of Revenue | 525,924 | | | Gross Profit | 90,183 | | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 50,622 | | Non Recurring | (813) | | Others | 334 | | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 40,040 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 789 | | Earnings Before Interest And Taxes | 40,829 | | Interest Expense | 1,701 | | Income Before Tax | 39,128 | | Income Tax Expense | 15,495 | | Minority Interest |
-
| | | | Net Income From Continuing Ops | 23,633 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 23,633 | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | $23,633 |
|
0.29% Nasdaq 
Income Statement
